		<rss version="2.0">
		<channel>
		<title>Serevent News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link>
		<description>What is Serevent?
Serevent is an asthma drug manufactured by GlaxoSmithKline.  Asthma is a condition in which inflammation of the airways causes airflow to and from the lungs to be restricted.  An estimated 16 million patients in the U.S. have asthma, and the number of asthmatics has increased significantly in recent decades.  The FDA approved Serevent Inhalation Aerosol in 1994 to treat asthma.  This approval was later extended to use for treatment of chronic obstructive pulmonary disease (COPD).  Serevent belongs to the class of asthma medications known as beta2-receptor agonists (commonly called &#34;beta agonists&#34;). The ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
					<item>
			<title>Long-acting asthma drugs called risky in new report</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>WASHINGTON - Long-acting asthma medicines such as Advair and Serevent pose a substantially increased risk of hospitalization and death to users compared with placebos, according to a new analysis of 1...</description>			
			</item>			
					<item>
			<title>Trouble Breathing</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>The world&#39;s most popular asthma drug may sometimes kill the patients it is supposed to help.</description>			
			</item>			
					<item>
			<title>Advair, Other Asthma Drug Get Label Alerts</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>Washington (AP) - The asthma medication Advair and a related drug will bear stronger warnings of an increased risk of death associated with one of their ingredients. The revised warnings apply to Adva...</description>			
			</item>			
					<item>
			<title>Advair, Other Asthma Drug Get Label Alerts</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>Advair and a Second GlaxoSmithKline Asthma Drug Get Stronger Warning Labels</description>			
			</item>			
					<item>
			<title>Common Asthma Medication Poses Risk to Black Patients</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Serevent-P17/News/</link><description>(The New York Times News Service) -- A large study on the popular asthma medication salmeterol was halted after researchers uncovered evidence that the drug may pose a slightly higher risk for respira...</description>			
			</item>			
				
		</channel>
		</rss> 
		